📰 Lockbody Technology Platform News
Lockbody Technology Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lockbody Technology Platform. Real-time updates on events, politics, business and more.
March 28, 2024
Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist...
August 14, 2023
Enrollment and dosing ongoing in registrational study of SerpinPC for the treatment of hemophilia BEnrollment and dosing ongoing in Phase 1/2a Stu...
May 23, 2023
Registered number: 12973576 CENTESSA PHARMACEUTICALS PLC PARENT COMPANY FINANCIAL STATEMENTS FOR THE YEAR ENDED 31... | May 23, 2023
May 12, 2023
- Strong clinical momentum and cash runway into 2026 to support multiple clinical readouts across pipeline - Advancing registration program for SerpinPC to treat hemophilia B; Enrolling subjects in
May 12, 2023
– Strong clinical momentum and cash runway into 2026 to support multiple clinical readouts across pipeline – Advancing registration program for SerpinPC to treat hemophilia B; Enrolling... | May 12, 2023
March 30, 2023
Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022